FOSCHI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 5.790
AS - Asia 3.463
EU - Europa 2.504
SA - Sud America 835
AF - Africa 109
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.708
Nazione #
US - Stati Uniti d'America 5.583
SG - Singapore 1.371
IT - Italia 770
RU - Federazione Russa 725
BR - Brasile 667
CN - Cina 487
HK - Hong Kong 437
VN - Vietnam 436
BD - Bangladesh 353
DE - Germania 190
FR - Francia 182
FI - Finlandia 146
NL - Olanda 130
CA - Canada 113
IN - India 107
GB - Regno Unito 98
MX - Messico 67
AR - Argentina 65
AT - Austria 48
ES - Italia 39
EC - Ecuador 37
ID - Indonesia 36
IQ - Iraq 33
PL - Polonia 33
ZA - Sudafrica 33
JP - Giappone 32
SE - Svezia 30
IE - Irlanda 23
CL - Cile 20
TR - Turchia 19
CO - Colombia 18
ET - Etiopia 18
IR - Iran 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
PK - Pakistan 15
MY - Malesia 14
SA - Arabia Saudita 14
PY - Paraguay 13
UA - Ucraina 13
DZ - Algeria 11
LT - Lituania 11
MA - Marocco 10
TH - Thailandia 10
KZ - Kazakistan 9
TN - Tunisia 9
CH - Svizzera 7
RO - Romania 7
VE - Venezuela 7
EG - Egitto 6
IL - Israele 6
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
CZ - Repubblica Ceca 5
HN - Honduras 5
HU - Ungheria 5
NP - Nepal 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KR - Corea 4
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
CG - Congo 3
CR - Costa Rica 3
GR - Grecia 3
GT - Guatemala 3
KE - Kenya 3
PS - Palestinian Territory 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
BO - Bolivia 2
DK - Danimarca 2
GA - Gabon 2
GD - Grenada 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
Totale 12.693
Città #
Dallas 2.312
Singapore 754
San Jose 720
Hong Kong 428
Council Bluffs 410
Ashburn 403
Santa Clara 260
Boardman 159
Ho Chi Minh City 142
The Dalles 128
New York 127
Moscow 123
Los Angeles 118
Lauterbourg 113
Hanoi 106
Beijing 83
Lappeenranta 83
Hefei 78
São Paulo 65
Munich 52
Milan 51
Orem 46
Rome 45
Frankfurt am Main 38
Montreal 38
Mexico City 37
Verona 37
Toronto 35
Helsinki 34
L’Aquila 29
Warsaw 28
Da Nang 27
Rio de Janeiro 26
Turku 25
Stockholm 23
Shanghai 22
West Jordan 22
Chennai 21
London 21
Bologna 20
Denver 20
Haiphong 20
Tokyo 20
Curitiba 19
Naples 19
Benevento 18
Brooklyn 18
Dublin 18
Düsseldorf 18
Turin 18
Amsterdam 17
Atlanta 17
Guayaquil 17
Mumbai 17
Nuremberg 17
Chicago 15
Johannesburg 15
Poplar 15
Tashkent 15
Ankara 14
Boston 14
Charlotte 14
Buffalo 13
Phoenix 13
Vienna 13
Brasília 12
Houston 12
City of London 11
Florence 11
Kitzingen 11
Manchester 11
Spoltore 11
St Louis 11
Chandler 10
Falkenstein 10
Ha Long 10
Jakarta 10
Seattle 10
Taizhou 10
Baghdad 9
Belo Horizonte 9
Campinas 9
Hải Dương 9
Madrid 9
New Delhi 9
Palermo 9
Piscataway 9
Salvador 9
Santiago 9
Addis Ababa 8
Assago 8
Bari 8
Pescara 8
Ribeirão Preto 8
Thái Bình 8
Biên Hòa 7
Changsha 7
Columbus 7
Jinan 7
Kuala Lumpur 7
Totale 8.026
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 353
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis 350
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features 295
Implementing Blood Biomarkers in Stroke Research and Clinical Practice 290
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 283
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years 278
Persistent progression independent of relapse activity in multiple sclerosis 219
High-Density Lipoprotein Cholesterol Levels and their impact on outcomes in acute ischemic stroke patients treated with mechanical thrombectomy 210
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 168
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 166
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 166
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 164
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 156
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 154
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 150
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 148
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke 139
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 136
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 135
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 135
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 133
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 126
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 124
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 124
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 121
How far are we from bringing intensive care bundle for intracerebral hemorrhage into the real-world setting? A 5-year population based-study 117
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 116
Do antithrombotic drugs have a role in migraine prevention? A systematic review 112
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 112
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 108
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 105
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 99
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 98
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 98
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 98
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 95
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 95
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 93
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 92
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis 90
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 89
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 88
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 88
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 88
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 84
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study 82
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 82
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024) 81
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 81
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 80
Impact of Sex on Clinical Outcomes of Tandem Occlusion in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy. A Propensity‐Matched Analysis 80
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 79
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials 79
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 79
The Italian Multiple Sclerosis Register Experience With Cladribine 78
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 78
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 78
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 77
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 75
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 75
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 75
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 73
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability 73
Switch from fingolimod to ozanimod for safety or intolerance reasons 73
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 72
Antithrombotic treatment of cervical arterial dissection: Big data needed to inform long-term management 71
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 71
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 70
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort 70
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 69
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 69
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 68
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 68
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 66
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study 65
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 65
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 65
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 64
A call for academic pragmatic clinical trials to address open questions in migraine prevention 64
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 63
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 63
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 63
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 63
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 62
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 61
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 61
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 59
Annual level changes of serum neuronal and glial biomarkers in a German professional football club 59
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 58
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 57
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 57
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 57
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 56
Impact of Atrial Fibrillation on Outcomes in Stroke Patients with Tandem Occlusions Treated with Thrombectomy.A multicentre study 56
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 55
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 55
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 55
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 54
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 53
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 52
Totale 10.402
Categoria #
all - tutte 47.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20252.742 106 28 195 99 229 178 292 205 629 259 264 258
2025/20269.669 277 2.307 793 1.073 564 341 1.066 464 754 772 732 526
Totale 12.903